.
Search
Dr. Ashkan Shoamanesh and Dr. C. Michael Gibson discuss findings presented at the recent ESOC meeting about what the latest data reveals about asundexian and ischemic stroke prevention.
We examine the characteristics and severity of ischemic strokes occurring during the study, the consistency of treatment benefit over time, […]
Dr. Ahmad Masri and Dr. C. Michael Gibson discuss findings presented at the HFSA2026 examining the association between an early eGFR dip following acoramidis initiation and the risk of all-cause mortality and recurrent cardiovascular-related hospitalizations.
The post hoc analysis of ATTRibute-CM found that acoramidis was associated with a consistent benefit on these outcomes through month […]